FDA NDC Directory · JSON-LD · Markdown

Lyrica

NDC 0071-1018 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namePREGABALIN
Labeler / ManufacturerParke-Davis Div of Pfizer Inc
Marketing categoryNew Drug Application (innovator) · App NDA021446
Dosage form / routeCAPSULE · ORAL
Active ingredientsPREGABALIN (300 mg/1)
Marketing started20041230
Marketing ended20261231
Package count1

External sources

Source: openFDA. Public-domain (CC0).